# Rasagiline

## Rakinson 1mg

| TAH Drug Code      | [ORAK](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORAK)                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Parkinson's disease                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Monotherapy: 1 mg once daily Adjunctive therapy with levodopa: Initial: 0.5 mg once daily; may increase to 1 mg once daily based on response and tolerability                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Concomitant use with MAOIs (including other selective MAO-B inhibitors)， meperidine， methadone， propoxyphene， or tramadol due to the risk of serotonin syndrome; allow at least 14 days between rasagiline discontinuation and initiation of these agents. Concomitant use with cyclobenzaprine or St. John's wort. Concomitant use with dextromethorphan due to the risk of psychotic episodes or bizarre behavior. Severe liver function impairment. |
| Adverse Effects    | Common: Orthostatic hypotension (3-44%)， Peripheral edema (7%)， Rash (3-6%)， Weight decreasing (2-9%)， Constipation (4-9%)， Indigestion (4-7%)， Nausea (6-12%)， Vomiting (4-7%)， Xerostomia (2-6%)， Arthralgia (5-11%)， Ataxia (3-6%)， Dizziness (7%)， Dyskinesia (18%)， Headache (6-14%)， Depression (5%)， Falling injury (5-12%)， Influenza-like illness (5%) Serious: Hypertension (4%)， Compulsive behavior， Serotonin syndrome      |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/rasagiline-drug-information)                                                                                                                                                                                                                                                                                                                                                                                  |

